PP282—The role of cbs and H2S in the induction of torpor and organ preservation during hibernation  by Dugbartey, G.J. & Henning, Robert H.
Clinical Therapeutics
e106 Volume 35 Number 8S
PP280—Blood leVelS of CyCloSPoriNe a 
aNd iTS firST liNe meTaBoliTeS duriNg aN 
early faSe afTer reNal TraNSPlaNTaTioN  
iN PaTieNTS wiTh Normal aNd delayed 
grafT fuNCTioN
M. Grundmann1*; P. Halvova2; H. Brozmanova1; J. Dedochova3; 
and A. Martinek3
1Dept. of Clinical Pharmacology, Faculty of Medicine University 
of Ostrava; 2Dept. of Clinical Pharmacology; and 3Dept. of 
Internal Medicine, University Hospital Ostrava, Ostrava, Czech 
Republic
Introduction: Acute rejection (AR) and delayed graft function 
(DGF) are 2 main adverse early posttransplant events that one 
would like to avoid. DGF conventionally defined as requirement 
for dialysis during the first postperative week is a form of acute 
renal failure that results in posttransplant oligouria, increases risk of 
AR, and decreases graft survival. Higher incidence of DGF in renal 
transplant recipients treated by CsA was described previously, but 
the mechanism of this effect has not been explained yet. The aim 
of this study was to compare blood concentrations of CsA and its 
metabolites AM1, AM9, and AM4N in patients with immediate and 
DGF renal function.
Patients (or Materials) and Methods: Fourteen adult renal transplant 
recipients (8 males) were prospectively observed during the first 3 
months. The therapy was based on CsA microemulsion (Sandimun 
Neoral® or Equoral®) in combination with mycophenolate and 
prednisone and was adapted in accordance with guidelines and clini-
cal outcomes. First dose of CsA (4–8 mg/kg) was administered in 
the day of transplantation. On the basis of clinical status confirmed 
by serum creatinine level and creatinine clearance the subjects were 
divided in to 2 groups with immediate graft function (IF-7 patients) 
and with DGF (7 patients). The CsA and the metabolites C0, C2, and 
C4 concentrations were analyzed using LC-MS/MS method in days 
1 to 7, 14, 21, and 28.1
Results: Significant higher creatinine levels and significant lower 
creatinine clearance were found in DGF group (P < 0.05). During 
the first month the CsA C0 were significantly higher (237 [127] 
μ g/L vs 170 [72] μ g/L; P = 0.0002) while C2 and AUC0-4 were 
lower (698 [320] μ g/L vs 919 [412] μ g/L, 2162 [830] μ g*h/L vs 
2610 [1002] μ g*h/L; P < 0.01). The highest concentrations dif-
ferences were found in AM4N metabolite: C0 (66.5 [61] μ g/L vs 
7.5 [7.4] μ g/L), C2 (111 [93] ug/L vs 41 [34] ug/L), C4 (134 [131] 
μ g/L vs 32 [22] ug/L), AUC0–4 (415 [352] μ g*h/L vs 121 [91] 
μ g*h/L). AM4N/CsA ratio: C0 (0.3 [0.28] vs 0.05 [0.04]), C2 (0.19 
[0.17] vs 0.05 [0.04]), C4 (0.25 [0.25] vs 0.06 [0.04]). All results 
were significant for P < 0.0001. Similarly C0, C2, C4, AUC0–4 of 
AM1 and AM1/CsA ratio were significantly lower in DGF group 
(P < 0.001). The graft function in DGF group recovered between 
1 week and 2 months and the differences of CsA and metabolites 
concentrations disappeared.
Conclusion: Metabolismus of CsA in patients with IF and DGF was 
different. Higher concentrations of AM4N and AM1 should be cause 
or markers.Therefore, TDM of CsA in combination with fenotypiza-
tion is recommended.
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Introduction: Streptomycin, as other aminoglycosides, exhibits 
concentration-dependent bacterial killing but has a narrow thera-
peutic window. It is primarily eliminated unchanged by the kidneys. 
Data and dosing information to achieve a safe regimen in patients 
with chronic renal failure undergoing hemodialysis (HD) are scarce. 
Although main adverse reactions are related to prolonged, elevated 
serum concentrations, literature recommendation is to administer 
streptomycin after each HD.
Patients (or Materials) and Methods: We report the case of a patient 
with end-stage renal failure, undergoing HD, who was successfully 
treated with streptomycin for gentamicin-resistant Enterococcus 
faecalis bacteremia with prosthetic arteriovenous fistula infection. 
Streptomycin was administered intravenously 7.5 mg/kg, 3 hours 
before each dialysis (3 times a week) during 6 weeks in combination 
with amoxicillin. Streptomycin plasma levels were monitored with 
repeated blood sampling before, after, and between HD sessions. A 
2-compartment model was used to reconstruct the concentration time 
profile over days on and off HD.
Results: Streptomycin trough plasma-concentration was 2.8 mg/L. 
It peaked to 21.4 mg/L 30 minutes after intravenous administration, 
decreased to 18.2 mg/L immediately before HD, and dropped to 4.5 
mg/L at the end of a 4-hour HD session. Plasma level increased again 
to 5.7 mg/L 2 hours after the end of HD and was 2.8 mg/L 48 hours 
later, before the next administration and HD. The pharmacokinetics 
of streptomycin was best described with a 2-compartment model. 
The computer simulation fitted fairly well to the observed concentra-
tions during or between HD sessions. Redistribution between the 2 
compartments after the end of HD reproduced the rebound of plasma 
concentrations after HD. No significant toxicity was observed during 
treatment. The outcome of the infection was favorable, and no sign 
of relapse was observed after a follow-up of 3 months.
Conclusion: Streptomycin administration of 7.5 mg/kg 3 hours 
before HD sessions in a patient with end-stage renal failure resulted 
in an effective and safe dosing regimen. Monitoring plasma levels 
along with pharmacokinetic simulation document the suitability of 
this dosing scheme, which should replace current dosage recommen-
dations for streptomycin in HD.
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Introduction: Mammalian hibernation is characterized by profound 
reductions in metabolism and body temperature. As a result, hibernat-
ing animals enter a state of suspended animation called “torpor,” where 
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core body temperatures can drop to as low as approximately –3°C. 
This is followed by a state with full restoration of metabolism and 
body temperature called “arousal” without reperfusion injury or other 
ill effects. It has been recently reported that cooling of hamster cells 
increases endogenous production of H2S through cystathionine-β -syn-
thase (CBS) enzyme, which prevents apoptotic cell death. Therefore, 
in this study, we investigate the role of CBS and H-2S in the induction 
of torpor and organ preservation during hibernation by blocking CBS 
with the compound aminooxyacetic acid (AOAA).
Patients (or Materials) and Methods: Male Syrian golden hamsters 
(Mesocricetus auratus) were housed in cages in a climate-controlled 
chamber at 5°C under dim red light to induce torpor. Movement of all 
animals was continuously monitored with passive infrared detectors. 
Osmotic mini-pumps filled with saline or AOAA (100 mg/kg/d) were 
implanted IP during torpor after a bolus injection of AOAA (10 mg) 
under 2.5% isoflurane anesthesia. At 4 days after implantation of 
pumps, hamsters were aroused by handling for 4 hours and eutha-
nized under pentobarbital anesthesia . Blood samples were taken and 
kidneys of the hamsters were obtained. Summer euthermic hamsters 
served as controls.
Results: In contrast to saline infusions, infusion of AOAA prevented 
hamsters from re-entry into torpor. Infusion of AOAA also induced 
excess renal damage as indicated by high expression of kidney injury 
marker as well as changes in renal morphology. In contrast, renal 
morphology was well preserved during hibernation in the saline and 
nonhibernating summer control groups.
Conclusion: Blocking CBS during hibernation precludes animals 
from entering torpor and counteracts up-regulation of CBS enzyme 
in the kidney, thus inducing kidney damage. Endogenous H2S pro-
duction by activation or up-regulation of CBS may be instrumental 
to alleviate kidney damage in several clinically relevant conditions 
such as deep hypothermia, organ storage for transplantation, and 
ischemia-reperfusion.
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Introduction: Acute renal failure (ARF) is a state of rapid loss of 
kidney function. We have previously shown that chronic renal failure 
in rats induces changes in motor activity and behavior. There are 
no reports on the central nervous system after induction of nephro-
toxicity of cisplatin (CP) in mice. This is the subject matter of the 
current work.
Patients (or Materials) and Methods: CP was injected intraperito-
neally (IP) in a single dose of 20 mg/kg to induce a state of ARF, and 3 
days later, its effects on motor activity, thermal and chemical nocicep-
tive tests, neuromuscular coordination, pentobarbitone-sleeping time, 
and exploration activity, and 2 depression models were investigated. 
The platinum concentration in the kidneys and brains of treated 
mice was also measured. The occurrence of CP nephrotoxicity was 
ascertained by standard physiological, biochemical, and histopatho-
logic methods.
Results: CP induced all the classical biochemical, physiological, and 
histopathologic signs of nephrotoxicity. The average renal platinum 
concentration of CP-treated mice was 5.16 ppm. However, no meas-
urable concentration of platinum was found in the whole brains of 
CP-treated mice. CP treatment significantly decreased motor and 
exploration activities, and decreased immobility time in depression 
models, possibly suggesting a depression-like state. Also, the time 
taken by the treated mice on the hot plate and tail flick tests was sig-
nificantly prolonged compared with the control, indicating possible 
anti-nociceptive action of CP. There was also a significant decrease 
in neuromuscular coordination in CP-treated mice.
Conclusion: CP, given at a nephrotoxic dose, induced several adverse 
motor and behavioral alterations in mice. Further behavioral tests 
and molecular and biochemical investigations in the brains of mice 
with CP-induced ARF are warranted.
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Introduction: Particulate air pollution with particle diameter < 2.5 
μ m contributes to respiratory and extra-respiratory morbidity and 
mortality. We have recently reported the first in vivo experimental 
evidence that diesel exhaust particles (DEP) in the lung aggravated the 
renal, pulmonary, and systemic effects of cisplatin (CP)-induced acute 
renal failure in rats. This in vitro study sought to determine whether 
and to what extent does DEP exposure exacerbate the effects of 
CP-induced oxidative stress in human embryonic kidney (HEK-293) 
cells, and to examine if these effects could be mitigated/prevented 
with curcumin (the yellow pigment isolated from turmeric).
Patients (or Materials) and Methods: Cells viability, cysteine uptake, 
and oxidative stress indices (glutathione [GSH], total antioxidant 
capacity [TAC]), and antioxidant enzymes (catalase; glutathione per-
oxidase; superoxide dismutase) were evaluated by standard methods 
in all study groups.
Results: DEP aggravated the CP-induced HEK-293 cells toxicity as 
evidenced by decreasing cells viability and inducing oxidative stress 
(GSH depletion, TAC impairment, and antioxidant enzymes inhibi-
tion). DEP selectively inhibited the cysteine uptake; meanwhile, CP 
had no effect. Curcumin significantly prevented the observed DEP 
and CP-induced cellular insults.
Conclusion: DEP augmented the CP-induced toxicity in HEK-293 
cells. Curcumin protected the cells against DEP and CP-induced tox-
icity through its potent antiantioxidant action.
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